Articles tagged "Survival"

2019 American Transplant Congress
Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction
S. Mietz¹, D. Roe², E. Lushin¹, E. Anderson¹, C. Hage²
¹Pharmacy, Indiana University Health, Indianapolis, IN, ²Pulmonary Critical Care, Indiana University Health, Indianapolis, IN
*Purpose: Compare alemtuzumab and basiliximab used for lung transplant in terms of rejection, CLAD, and mortality.*Methods: A retrospective review of lung transplants performed between 2010…
2019 American Transplant Congress
A Priori Identification of Hard-to-Place Livers
A. Wey¹, N. Hadley¹, J. Rosendale², R. Hunter², J. Prinz², K. Audette¹, N. Salkowski¹, D. Zaun¹, J. Snyder³
¹SRTR, Minneapolis, MN, ²OPTN, Richmond, VA, ³SRTR, Mineeapolis, MN
*Purpose: Identification of hard-to-place deceased donor livers is important due to its potential role in expedited placement. Determining hard-to-place must be based on data available…
2019 American Transplant Congress
Actions Speak Louder Than Labs – The Impact of Dialysis Compliance on Posttransplant Outcomes
D. Sawinski¹, H. Lindner², J. Schults³, J. Locke⁴, P. Reese¹
¹Hospital of the U of Pennsylvania, Philadelphia, PA, ²University of Pennsylvania, Philadelphia, PA, ³Children's Hospital of Pennsylvania, Philadelphia, PA, ⁴University of Alabama at Birmingham, Birmingham, AL
*Purpose: Non-adherence is a modifable risk factor for poor posttransplant outcomes. While the factors contributing to posttransplant non-adherence are complex, noncompliance with the dialysis prescription…
2019 American Transplant Congress
Liver Transplantation for Acute Liver Failure: A 16 Year Experience with 214 Patients in the Post-MELD Era
R. McMillan, T. Ito, A. Aziz, A. Amin, A. Murray, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Liver transplantation (LT) remains the gold standard treatment for acute liver failure (ALF). Our center has previously reported outcomes in the pre-Model for End…
2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
S. Alghamdi, O. Altayar, T. Zhu, A. Bayudan, J. Fleckenstein, M. Lisker-Melman, J. Crippin, A. Flores
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…
2019 American Transplant Congress
Short and Long Term Outcomes of Retrograde vs Antegrade Reperfusion of Liver Transplants. A Propensity Matched Pair Analysis
H. Sharma, B. Shrum, D. Quan, A. Skaro, W. Wall, V. McAlister.
Transplant Surgery, University of Western Ontario, London, ON, Canada
*Purpose: There are no published studies to compare long-term outcomes of retrograde-reperfusion-technique (RR) compared to antegrade-reperfusion-technique (AR) in liver-transplantation (LT). This retrospective-cohort-study compares short/long-term outcomes…
2019 American Transplant Congress
Sustained Biologic Response To Neoadjuvant Therapy Predicts Excellent Liver Transplant Outcomes For Locally Advanced Intrahepatic Cholangiocarcinoma
K. E. Lunsford¹, M. Javle², K. Heyne³, R. A. Ali², C. M. Mobley¹, A. Saharia¹, D. W. Victor¹, M. J. Hobeika¹, A. Kasab², R. S. McFadden¹, T. A. Aloia², X. C. Li¹, H. P. Monsour¹, A. O. Gaber¹, A. O. Gaber¹, J. Vauthey², R. M. Ghobrial¹
¹J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX, ²The University of Texas MD Anderson Cancer Center, Houston, TX, ³Department of Oncology, Houston Methodist Hospital, Houston, TX
*Purpose: Intrahepatic cholangiocarcinoma (iCCA) is a contraindication for liver transplant (LT), but prior studies limited evaluation to incidental iCCA. We recently reported significant improvement in…
2019 American Transplant Congress
Multi-Organ Transplant Results in Lower Patient and Graft Survival Than Kidney Alone Transplant
C. A. Custer¹, J. Entwistle², K. Ladin³, L. Cartwright¹, E. J. Gordon⁴
¹United Network for Organ Sharing, Richmond, VA, ²Thomas Jefferson University, Washington, DC, ³Tufts University, Medford, MA, ⁴Northwestern University, Chicago, IL
*Purpose: Kidneys are the most common organ involved in multi-organ transplants (MOT). MOT candidates often receive priority access to kidneys over single organ transplant (SOT)…
2019 American Transplant Congress
The Liver Frailty Index is Associated with Current and Subsequent Disability in Liver Transplant Candidates
J. C. Lai, J. L. Dodge, C. E. McCulloch, K. E. Covinsky, J. P. Singer
University of California, San Francisco, San Francisco, CA
*Purpose: The Liver Frailty Index (LFI) was developed to capture the effects of malnutrition and muscle wasting in patients with cirrhosis awaiting liver transplantation (LT).…
2019 American Transplant Congress
Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience
O. Y. Mousa¹, K. D. Watt¹, J. K. Heimbach², A. P. Keaveny³, J. E. Eaton¹, D. M. Harnois³, B. Taner³, E. J. Carey⁴, A. A. Moss⁴, C. B. Rosen⁵, T. Taner⁵
¹Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ²Department of Surgery, Mayo Clinic, Rochester, MN, ³Department of Transplant, Mayo Clinic, Jacksonville, FL, ⁴Department of Transplant, Mayo Clinic, Scottsdale, AZ, ⁵Department of Transplant, Mayo Clinic, Rochester, MN
*Purpose: MELD-based allocation is known to reduce access to deceased donor liver transplantation (DDLT) for patients with primary sclerosing cholangitis (PSC). Living donor liver transplantation(LDLT)…